Trademark: 90217689
Word
AXIAL THERAPEUTICS
Status Date
Tuesday, April 9, 2024
Registration Number
7355827
Registration Date
Tuesday, April 9, 2024
Filing Date
Monday, September 28, 2020
Published for Opposition
Tuesday, November 23, 2021
5 Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
1 Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
44 Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals
42 Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
The mark consists of eight circles, each connected to a central donut circle by two horizontal lines at the left and right, one shorter vertical line at the top, one longer vertical line at the bottom, one short diagonal line at the lower-left, one longer diagonal line at the upper-left, one slightly longer diagonal line at the upper-right, and one longer diagonal line at the lower right. To the right of this is the stacked stylized wording "AXIAL THERAPEUTICS" where "AXIAL" is in larger-sized font and "THERAPEUTICS" is in smaller-sized font.
"THERAPEUTICS"
Apr 9, 2024
Registered-Principal Register
Mar 7, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 6, 2024
Allowed Principal Register - Sou Accepted
Feb 26, 2024
Teas/Email Correspondence Entered
Feb 26, 2024
Correspondence Received In Law Office
Feb 26, 2024
Assigned To Lie
Oct 4, 2023
Teas Response To Office Action Received
Jul 18, 2023
Sou Teas Extension Received
Jun 21, 2023
Application Extension Granted/Receipt Provided
Jun 21, 2023
Application Extension To Response Period - Received
Apr 4, 2023
Notification Of Non-Final Action E-Mailed
Apr 4, 2023
Non-Final Action E-Mailed
Apr 4, 2023
Su - Non-Final Action - Written
Mar 6, 2023
Statement Of Use Processing Complete
Feb 17, 2023
Use Amendment Filed
Mar 6, 2023
Case Assigned To Intent To Use Paralegal
Feb 17, 2023
Teas Statement Of Use Received
Jan 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 11, 2023
Sou Extension 2 Granted
Jan 11, 2023
Sou Extension 2 Filed
Jan 11, 2023
Sou Teas Extension Received
Jun 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 17, 2022
Sou Extension 1 Granted
Jun 17, 2022
Sou Extension 1 Filed
Jun 17, 2022
Sou Teas Extension Received
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Published For Opposition
Nov 3, 2021
Notification Of Notice Of Publication E-Mailed
Oct 15, 2021
Approved For Pub - Principal Register
Sep 18, 2021
Teas/Email Correspondence Entered
Sep 17, 2021
Correspondence Received In Law Office
Sep 17, 2021
Teas Response To Office Action Received
Mar 24, 2021
Automatic Update Of Assignment Of Ownership
Mar 22, 2021
Notification Of Non-Final Action E-Mailed
Mar 22, 2021
Non-Final Action E-Mailed
Mar 22, 2021
Non-Final Action Written
Feb 25, 2021
Examiner's Amendment Entered
Feb 25, 2021
Notification Of Examiners Amendment E-Mailed
Feb 25, 2021
Examiners Amendment E-Mailed
Feb 25, 2021
Examiners Amendment -Written
Feb 19, 2021
Assigned To Examiner
Nov 11, 2020
Notice Of Design Search Code E-Mailed
Nov 10, 2020
New Application Office Supplied Data Entered
Oct 1, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
